Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter

Investor News

Clinical Development News
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
Approvable Letters
Approval and Marketing Clearance
Recalls and Warnings

Deals & Dollars News
Earnings Reports
Mergers and Acquisitions

IPO News

Clinical - Phase I
Novaliq GmbH Reports Positive Results From Cyclasol® (Cyclosporin Solution) Eye Drops Repeated And Ascending Dose Phase 1 Study 9/23/2014 10:56:09 AM
MedImmune (AZN) Receives Fast Track Designation From FDA For Development Of MEDI3902 For Prevention Of Nosocomial Pneumonia 9/23/2014 10:42:42 AM
Novavax, Inc. (NVAX)' H7n9 Avian Influenza VLP Vaccine Candidate With Matrix-M™ Delivers Positive Phase 1/2 Clinical Data 9/23/2014 8:21:47 AM
Promedior Announces Presentation Of Retrospective Quantitative Imaging Analysis Of Phase 1b Data In Idiopathic Pulmonary Fibrosis 9/22/2014 9:16:57 AM
NeuralStem Inc. ALS Investigator Presents Long-Term Follow Up Phase I Data 9/22/2014 8:21:26 AM
Pressure BioSciences, Inc. (BBII) Announces Completion Of The First Phase Of Its Commercialization Plan For The Barozyme HT48, The Company's Recently Released High Throughput PCT-Based Instrument System 9/19/2014 7:24:25 AM
SWOG To Resume Clinical Trial Of Halozyme Therapeutics, Inc. (HALO)'s PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 9/18/2014 10:05:54 AM
Capricor Therapeutics, Inc. Presents Safety And Preliminary Efficacy Results From ALLSTAR Phase I Clinical Trial At TCT 2014 9/18/2014 7:47:07 AM
Concert Pharmaceuticals, Inc. (CNCE) Announces Initiation Of CTP-730 Phase 1 Clinical Trial Under Celgene (CELG) Collaboration 9/17/2014 9:25:54 AM
Experimental Northwest Biotherapeutics (NWBO) Drug Gets First Slot Under UK Early Access Scheme 9/16/2014 6:00:01 AM
DNAtrix, Inc. Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial 9/16/2014 9:58:19 AM
Cleveland Biolabs Inc. (CBLI) Announces Approval To Start Phase 1 Study For Hematopoietic Stem Cell Mobilizer CBLB612 In Russian Federation 9/16/2014 9:34:06 AM
TapImmune Inc. (TPIV) Releases Positive Interim Data On Phase I Clinical Trial Of Folate Receptor Alpha Antigens In Ovarian And Breast Cancer 9/16/2014 8:55:22 AM
Virology Publishes Genocea Biosciences HSV-2 Antigen Discovery Paper 9/16/2014 8:30:01 AM
First European Patients Enrolled In QT QT Vascular's ENDURE Trial 9/16/2014 7:19:24 AM